Literature DB >> 27496874

Expression of sirtuins 1, 6, tumor necrosis factor, and interferon-γ in psoriatic patients.

H Rasheed1, Mhm El-Komy1, R A Hegazy1, H I Gawdat2, A M AlOrbani1, O G Shaker3.   

Abstract

Sirtuins (SIRT) have been regarded as culprits in the pathogenesis of various diseases. Their exact role has not been explained. This study aimed to assess the expression of SIRT1, SIRT6, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ in psoriatic patients. Thirty psoriatic patients and 22 controls were enrolled. Clinical examination and Psoriasis Area and Severity Index (PASI) were obtained. Two skin biopsies (lesional, peri-lesional) and one from controls were obtained. Tissue levels of SIRT1, SIRT6, TNF-α, and IFN-γ were measured using ELISA. SIRT1 was significantly lower in lesional skin with gradual increase in perilesional followed by control skin (P <0.001). SIRT6, TNF-α, and IFN-γ were significantly higher in lesional than perilesional and control skin (P <0.001). Significant positive correlations were found between SIRT1 and TNF-α, IFN-γ and between SIRT6 and TNF-α in peri-lesional skin. SIRT1 and SIRT6 are potentially involved in the pathogenesis of psoriasis. Modulating their action could offer a novel therapy for such disease.
© The Author(s) 2016.

Entities:  

Keywords:  IFN-γ; Pathogenesis; Psoriasis; Sirtuins 1 and 6; TNF-α

Mesh:

Substances:

Year:  2016        PMID: 27496874      PMCID: PMC5806820          DOI: 10.1177/0394632016662475

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  15 in total

1.  STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.

Authors:  Rosanna Sestito; Stefania Madonna; Claudia Scarponi; Francesca Cianfarani; Cristina M Failla; Andrea Cavani; Giampiero Girolomoni; Cristina Albanesi
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

2.  Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris.

Authors:  Peng Zhang; Yuwen Su; Ming Zhao; Wei Huang; Qianjin Lu
Journal:  Eur J Dermatol       Date:  2011 Jul-Aug       Impact factor: 3.328

3.  SIRT1 Activation Ameliorates Aldara-Induced Psoriasiform Phenotype and Histology in Mice.

Authors:  Sijing Xie; Zhonglan Su; Bin Zhang; Jiuyu Ge; Shiyu Song; Guibo Sun; Xiaobo Sun; Long Yi; Yong Wang; Weibin Sun; Hongwei Wang; Qian Gao
Journal:  J Invest Dermatol       Date:  2015-03-03       Impact factor: 8.551

Review 4.  Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.

Authors:  Batya B Davidovici; Naveed Sattar; Jörg C Prinz; Prinz C Jörg; Luis Puig; Paul Emery; Jonathan N Barker; Peter van de Kerkhof; Mona Ståhle; Frank O Nestle; Giampiero Girolomoni; James G Krueger
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

5.  Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.

Authors:  Amarjit Saini; Nasser Al-Shanti; Adam P Sharples; Claire E Stewart
Journal:  Exp Physiol       Date:  2011-11-28       Impact factor: 2.969

Review 6.  Mammalian sirtuins: biological insights and disease relevance.

Authors:  Marcia C Haigis; David A Sinclair
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

Review 7.  Sirtuins in dermatology: applications for future research and therapeutics.

Authors:  Melissa Serravallo; Jared Jagdeo; Sharon A Glick; Daniel M Siegel; Neil I Brody
Journal:  Arch Dermatol Res       Date:  2013-02-03       Impact factor: 3.017

8.  Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Authors:  Fan Yeung; Jamie E Hoberg; Catherine S Ramsey; Michael D Keller; David R Jones; Roy A Frye; Marty W Mayo
Journal:  EMBO J       Date:  2004-05-20       Impact factor: 11.598

9.  Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts.

Authors:  Xiaoxia Zhu; Qiong Liu; Meimei Wang; Minrui Liang; Xue Yang; Xue Xu; Hejian Zou; Jianhua Qiu
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

10.  A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis.

Authors:  James G Krueger; Mayte Suárez-Fariñas; Inna Cueto; Artemis Khacherian; Robert Matheson; Lawrence C Parish; Craig Leonardi; Denise Shortino; Akanksha Gupta; Jonathan Haddad; George P Vlasuk; Eric W Jacobson
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more
  5 in total

Review 1.  Role of Epigenetics in the Regulation of Immune Functions of the Skin.

Authors:  Yu Sawada; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2020-11-27       Impact factor: 8.551

2.  Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis.

Authors:  Lea Shallev; Eli Kopel; Ariel Feiglin; Gil S Leichner; Dror Avni; Yechezkel Sidi; Eli Eisenberg; Aviv Barzilai; Erez Y Levanon; Shoshana Greenberger
Journal:  RNA       Date:  2018-03-28       Impact factor: 4.942

3.  Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis.

Authors:  Matteo Becatti; Victoria Barygina; Amanda Mannucci; Giacomo Emmi; Domenico Prisco; Torello Lotti; Claudia Fiorillo; Niccolò Taddei
Journal:  Int J Mol Sci       Date:  2018-05-25       Impact factor: 5.923

4.  The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis.

Authors:  Azza M Elamir; Olfat G Shaker; Mohamed Hm El-Komy; Mai Mahmoud Sharabi; Nesreen M Aboraia
Journal:  Biochem Biophys Rep       Date:  2021-05-25

Review 5.  Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis.

Authors:  Joanna Pleńkowska; Magdalena Gabig-Cimińska; Paweł Mozolewski
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.